Chromatin immunoprecipitation (ChIP) indeed revealed binding of both FoxO1 and FoxO3a to the regulatory regions of the sox2 gene in GBM-SCs, independent of the p53 status (Figure 5E and 5J). The gene discussed is FOXO1; the disease is glioblastoma.